News & Press

Dr. Richard Harding has completed advanced training in Microwave Ablation, a minimally invasive thermal technique used to treat benign thyroid nodules while preserving thyroid function. This training expands the Thyroid Nodule Treatment Center’s suite of non‑surgical treatment options, complementing Thyroid Nodule Radiofrequency Ablation (RFA) and Thyroid Nodule Cell FX NanoPulse Ablation (nsPFA). The addition of Thyroid Nodule Microwave Ablation (MWA) reflects Dr. Harindg’s commitment to offering patients the most up‑to‑date, gland‑preserving alternatives to intrusive surgery.

Dr. Richard Harding presented advanced thermal ablation techniques for benign thyroid nodules at the 94th Annual American Thyroid Association (ATA) Meeting in Scottsdale. His session highlighted the expanding role of minimally invasive treatments such as Radiofrequency Ablation (RFA) and other emerging technologies in thyroid nodule management. This presentation reflects Dr. Harding’s continued leadership in educating clinicians and advancing non‑surgical thyroid care.

Dr. Richard Harding has introduced CellFX NanoPulse Ablation (nsPFA) as a new minimally invasive treatment option for benign thyroid nodules available at the Thyroid Nodule Treatment Center. This non‑thermal technology uses ultra‑short electrical pulses to target nodule tissue while preserving surrounding structures, offering an alternative for patients seeking non‑surgical care. Dr. Harding’s adoption of nsPFA reflects his commitment to expanding safe, gland‑preserving thyroid treatments.

The Thyroid Nodule Treatment Center is promoting Thyroid Awareness Month by encouraging patients and the public to learn about thyroid nodules, understand common symptoms, and seek appropriate evaluation. The campaign highlights the importance of early detection and provides educational resources to help individuals recognize when a thyroid nodule should be assessed. This initiative reflects Dr. Harding’s commitment to community education and proactive thyroid health.

Dr. Richard Harding presented at the 2nd Annual North American Society for Interventional Thyroidology (NASIT) Meeting, a multidisciplinary gathering focused on advancing safe, evidence‑based thyroid ablation techniques. As Program Chair, Dr. Harding contributed to discussions on innovation, clinical integration, and physician education in interventional thyroidology. His participation highlights his practice’s ongoing commitment to minimally invasive thyroid nodule treatment and professional leadership in the field.